✦ LIBER ✦

Stroke Prevention in Atrial Fibrillation and Other Major Cardiac Sources of Embolism

✍ Scribed by Freeman, William D.; Aguilar, Maria I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stroke severity in concomitant cardiac s

✍ Young Dae Kim; Bosuk Park; Myoung Jin Cha; Chung Mo Nam; Hyo Suk Nam; Jong Won H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Is left atrial appendage occlusion usefu

✍ Stöllberger, C. ;Finsterer, J. ;Ernst, G. ;Schneider, B. 📂 Article 📅 2002 🏛 Springer 🌐 German ⚖ 72 KB

Dabigatran versus rivaroxaban for the pr

✍ Kansal, A. R.; Sharma, M.; Bradley-Kennedy, C.; Clemens, A.; Monz, B. U.; Peng, 📂 Article 📅 2012 🏛 Schattauer 🌐 English ⚖ 173 KB

Prediction of Stroke Risk in Atrial Fibr

✍ George Thomas; Bruce B. Lerman 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 215 KB

Spotlight on Dabigatran Etexilate in the

✍ Karly P. Garnock-Jones 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 130 KB

Detection of Atrial Fibrillation and Sec

✍ Hooman Kamel; Wade S. Smith 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 127 KB